The Biotime CEA Rapid Quantitative Test provides a rapid and accurate measurement of Carcinoembryonic Antigen (CEA), a glycoprotein that is normally present in low concentrations in healthy adults but can be elevated in certain malignant and benign conditions.

This assay is particularly useful in colorectal cancer screening and monitoring, as well as in evaluating other cancers such as pancreatic, breast, lung, and gastric. The quick and convenient format of this test allows clinicians to obtain timely results, enabling better treatment planning and patient management.